Found: 139
Select item for more details and to access through your institution.
Towards the Stable Binding of Mercury: Synthesis and Functionalization of Dibenzyldiazabicyclononane Scaffolds.
- Published in:
- European Journal of Organic Chemistry, 2024, v. 27, n. 25, p. 1, doi. 10.1002/ejoc.202400258
- By:
- Publication type:
- Article
Combination of [<sup>18</sup>F]FDG and [<sup>18</sup>F]PSMA-1007 PET/CT predicts tumour aggressiveness at staging and biochemical failure postoperatively in patients with prostate cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 6, p. 1763, doi. 10.1007/s00259-023-06585-7
- By:
- Publication type:
- Article
Improved automated one-pot two-step radiosynthesis of (S)-[<sup>18</sup>F]FETrp, a radiotracer for PET imaging of indoleamine 2,3-dioxygenase 1 (IDO1).
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2024, v. 9, n. 1, p. 1, doi. 10.1186/s41181-024-00256-0
- By:
- Publication type:
- Article
Radiosynthesis and biological evaluation of [<sup>18</sup>F]AG-120 for PET imaging of the mutant isocitrate dehydrogenase 1 in glioma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 4, p. 1085, doi. 10.1007/s00259-023-06515-7
- By:
- Publication type:
- Article
Correction to: Radiosynthesis and biological evaluation of [<sup>18</sup>F]AG-120 for PET imaging of the mutant isocitrate dehydrogenase 1 in glioma.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Production of Medical Radionuclides in the Center for Radiopharmaceutical Tumor Research—A Status Report.
- Published in:
- Instruments (2410-390X), 2024, v. 8, n. 1, p. 10, doi. 10.3390/instruments8010010
- By:
- Publication type:
- Article
Production of the PET radionuclide <sup>61</sup>Cu via the <sup>62</sup>Ni(p,2n)<sup>61</sup>Cu nuclear reaction.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2024, v. 9, n. 1, p. 1, doi. 10.1186/s41181-023-00233-z
- By:
- Publication type:
- Article
Preclinical evaluation of an <sup>18</sup>F-labeled N<sup>ε</sup>-acryloyllysine piperazide for covalent targeting of transglutaminase 2.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2024, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00231-1
- By:
- Publication type:
- Article
Alpha-Emitting Radionuclides: Current Status and Future Perspectives.
- Published in:
- Pharmaceuticals (14248247), 2024, v. 17, n. 1, p. 76, doi. 10.3390/ph17010076
- By:
- Publication type:
- Article
Preparation of 18 F-Labeled Tracers Targeting Fibroblast Activation Protein via Sulfur [ 18 F]Fluoride Exchange Reaction.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 12, p. 2749, doi. 10.3390/pharmaceutics15122749
- By:
- Publication type:
- Article
Lysyl Oxidases as Targets for Cancer Therapy and Diagnostic Imaging.
- Published in:
- ChemMedChem, 2023, v. 18, n. 18, p. 1, doi. 10.1002/cmdc.202300331
- By:
- Publication type:
- Article
Joint EANM/SNMMI procedure guideline for the use of <sup>177</sup>Lu-labeled PSMA-targeted radioligand-therapy (<sup>177</sup>Lu-PSMA-RLT).
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 9, p. 2830, doi. 10.1007/s00259-023-06255-8
- By:
- Publication type:
- Article
Radiofluorination of an Anionic, Azide-Functionalized Teroligomer by Copper-Catalyzed Azide-Alkyne Cycloaddition.
- Published in:
- Nanomaterials (2079-4991), 2023, v. 13, n. 14, p. 2095, doi. 10.3390/nano13142095
- By:
- Publication type:
- Article
Design and Biological Evaluation of Small-Molecule PET-Tracers for Imaging of Programmed Death Ligand 1.
- Published in:
- Cancers, 2023, v. 15, n. 9, p. 2638, doi. 10.3390/cancers15092638
- By:
- Publication type:
- Article
PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 5, p. 1466, doi. 10.1007/s00259-022-06089-w
- By:
- Publication type:
- Article
Synthesis of [<sup>18</sup>F]FMISO, a hypoxia-specific imaging probe for PET, an overview from a radiochemist's perspective.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00190-7
- By:
- Publication type:
- Article
Improved protocol for the radiosynthesis of [<sup>18</sup>F]FTC‐146: A potent and selective sigma‐1 receptor radioligand.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2023, v. 66, n. 3, p. 116, doi. 10.1002/jlcr.4018
- By:
- Publication type:
- Article
Efforts toward PET-Activatable Red-Shifted Silicon Rhodamines and Silicon Pyronine Dyes.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 3, p. 401, doi. 10.3390/ph16030401
- By:
- Publication type:
- Article
Cyclotron-Based Production of 67 Cu for Radionuclide Theranostics via the 70 Zn(p,α) 67 Cu Reaction.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 2, p. 314, doi. 10.3390/ph16020314
- By:
- Publication type:
- Article
Epigenetic drugs in somatostatin type 2 receptor radionuclide theranostics and radiation transcriptomics in mouse pheochromocytoma models.
- Published in:
- Theranostics, 2023, v. 13, n. 1, p. 278, doi. 10.7150/thno.77918
- By:
- Publication type:
- Article
Highlight selection of radiochemistry and radiopharmacy developments by editorial board.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2022, v. 7, n. 1, p. 1, doi. 10.1186/s41181-022-00177-w
- By:
- Publication type:
- Article
Efficient Production of the PET Radionuclide 133 La for Theranostic Purposes in Targeted Alpha Therapy Using the 134 Ba(p,2n) 133 La Reaction.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 10, p. 1167, doi. 10.3390/ph15101167
- By:
- Publication type:
- Article
Radiosynthesis and Preclinical Evaluation of an 18 F-Labeled Triazolopyridopyrazine-Based Inhibitor for Neuroimaging of the Phosphodiesterase 2A (PDE2A).
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 10, p. 1272, doi. 10.3390/ph15101272
- By:
- Publication type:
- Article
Modulating the pharmacokinetic profile of Actinium-225-labeled macropa-derived radioconjugates by dual targeting of PSMA and albumin.
- Published in:
- Theranostics, 2022, v. 12, n. 17, p. 7203, doi. 10.7150/thno.78043
- By:
- Publication type:
- Article
Fluorination of silyl prosthetic groups by fluorine mediated silyl ether linker cleavage: a concept study with conditions applicable in radiofluorination.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2022, v. 7, n. 1, p. 1, doi. 10.1186/s41181-022-00167-y
- By:
- Publication type:
- Article
Novel Radioiodinated and Radiofluorinated Analogues of FT-2102 for SPECT or PET Imaging of mIDH1 Mutant Tumours.
- Published in:
- Molecules, 2022, v. 27, n. 12, p. 3766, doi. 10.3390/molecules27123766
- By:
- Publication type:
- Article
Towards Optimized Bioavailability of <sup>99m</sup>Tc-Labeled Barbiturates for Non-invasive Imaging of Matrix Metalloproteinase Activity.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Development of Radiotracers for Imaging of the PD-1/PD-L1 Axis.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 6, p. 747, doi. 10.3390/ph15060747
- By:
- Publication type:
- Article
Automated radiosynthesis of the adenosine A<sub>2A</sub> receptor‐targeting radiotracer [<sup>18</sup>F]FLUDA.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2022, v. 65, n. 6, p. 162, doi. 10.1002/jlcr.3970
- By:
- Publication type:
- Article
Quantitation of the A 2A Adenosine Receptor Density in the Striatum of Mice and Pigs with [ 18 F]FLUDA by Positron Emission Tomography.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 5, p. 516, doi. 10.3390/ph15050516
- By:
- Publication type:
- Article
Dual-Labelling Strategies for Nuclear and Fluorescence Molecular Imaging: Current Status and Future Perspectives.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 4, p. N.PAG, doi. 10.3390/ph15040432
- By:
- Publication type:
- Article
A New Class of PSMA-617-Based Hybrid Molecules for Preoperative Imaging and Intraoperative Fluorescence Navigation of Prostate Cancer.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 267, doi. 10.3390/ph15030267
- By:
- Publication type:
- Article
Development and Biological Evaluation of the First Highly Potent and Specific Benzamide-Based Radiotracer [ 18 F]BA3 for Imaging of Histone Deacetylases 1 and 2 in Brain.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 324, doi. 10.3390/ph15030324
- By:
- Publication type:
- Article
Non-Invasive Assessment of Locally Overexpressed Human Adenosine 2A Receptors in the Heart of Transgenic Mice.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 3, p. 1025, doi. 10.3390/ijms23031025
- By:
- Publication type:
- Article
Radiolabeled PSMA Inhibitors.
- Published in:
- Cancers, 2021, v. 13, n. 24, p. 6255, doi. 10.3390/cancers13246255
- By:
- Publication type:
- Article
Rational Linker Design to Accelerate Excretion and Reduce Background Uptake of Peptidomimetic PSMA-Targeting Hybrid Molecules.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.248443
- By:
- Publication type:
- Article
Rational Linker Design to Accelerate Excretion and Reduce Background Uptake of Peptidomimetic PSMA-Targeting Hybrid Molecules.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.248443
- By:
- Publication type:
- Article
Radiolabeled Silicon-Rhodamines as Bimodal PET/SPECT-NIR Imaging Agents.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 11, p. 1155, doi. 10.3390/ph14111155
- By:
- Publication type:
- Article
Intraindividual comparison of [<sup>68</sup> Ga]-Ga-PSMA-11 and [<sup>18</sup>F]-F-PSMA-1007 in prostate cancer patients: a retrospective single-center analysis.
- Published in:
- EJNMMI Research, 2021, v. 11, n. 1, p. 1, doi. 10.1186/s13550-021-00845-z
- By:
- Publication type:
- Article
Rational Linker Design to Accelerate Excretion and Reduce Background Uptake of Peptidomimetic PSMA-Targeting Hybrid Molecules.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.248443
- By:
- Publication type:
- Article
Rational Linker Design to Accelerate Excretion and Reduce Background Uptake of Peptidomimetic PSMA-Targeting Hybrid Molecules.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 9, p. 1, doi. 10.2967/jnumed.120.248443
- By:
- Publication type:
- Article
Rational Linker Design to Accelerate Excretion and Reduce Background Uptake of Peptidomimetic PSMA-Targeting Hybrid Molecules.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.248443
- By:
- Publication type:
- Article
Rational Linker Design to Accelerate Excretion and Reduce Background Uptake of Peptidomimetic PSMA-Targeting Hybrid Molecules.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.248443
- By:
- Publication type:
- Article
The PSMA-11-derived hybrid molecule PSMA-914 specifically identifies prostate cancer by preoperative PET/CT and intraoperative fluorescence imaging.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 6, p. 2057, doi. 10.1007/s00259-020-05184-0
- By:
- Publication type:
- Article
Rational Linker Design to Accelerate Excretion and Reduce Background Uptake of Peptidomimetic PSMA-Targeting Hybrid Molecules.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 1, doi. 10.2967/jnumed.120.248443
- By:
- Publication type:
- Article
Rational Linker Design to Accelerate Excretion and Reduce Background Uptake of Peptidomimetic PSMA-Targeting Hybrid Molecules.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.248443
- By:
- Publication type:
- Article
Towards Targeted Alpha Therapy with Actinium-225: Chelators for Mild Condition Radiolabeling and Targeting PSMA—A Proof of Concept Study.
- Published in:
- Cancers, 2021, v. 13, n. 8, p. 1974, doi. 10.3390/cancers13081974
- By:
- Publication type:
- Article
Predicting the Risk of Metastases by PSMA-PET/CT—Evaluation of 335 Men with Treatment-Naïve Prostate Carcinoma.
- Published in:
- Cancers, 2021, v. 13, n. 7, p. 1508, doi. 10.3390/cancers13071508
- By:
- Publication type:
- Article
Rational Linker Design to Accelerate Excretion and Reduce Background Uptake of Peptidomimetic PSMA-Targeting Hybrid Molecules.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 4, p. 1, doi. 10.2967/jnumed.120.248443
- By:
- Publication type:
- Article
Highlight selection of radiochemistry and radiopharmacy developments by editorial board.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2021, v. 6, n. 1, p. 1, doi. 10.1186/s41181-021-00128-x
- By:
- Publication type:
- Article